{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T04:42:34Z","timestamp":1784954554899,"version":"3.55.0"},"reference-count":142,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.mcna.2005.06.002","type":"journal-article","created":{"date-parts":[[2005,10,19]],"date-time":"2005-10-19T17:38:58Z","timestamp":1129743538000},"page":"1277-1296","source":"Crossref","is-referenced-by-count":75,"title":["Toxin-Induced Hyperthermic Syndromes"],"prefix":"10.1016","volume":"89","author":[{"given":"Daniel E.","family":"Rusyniak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon E.","family":"Sprague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mcna.2005.06.002_bib1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/106002809603000207","article-title":"Oxybutynin-induced heatstroke in an elderly patient","volume":"30","author":"Adubofour","year":"1996","journal-title":"Ann Pharmacother"},{"issue":"6778","key":"10.1016\/j.mcna.2005.06.002_bib2","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/35007527","article-title":"Towards a molecular understanding of adaptive thermogenesis","volume":"404","author":"Lowell","year":"2000","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.mcna.2005.06.002_bib3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4065\/78.5.603","article-title":"Skin blood flow in adult human thermoregulation: how it works, when it does not, and why","volume":"78","author":"Charkoudian","year":"2003","journal-title":"Mayo Clin Proc"},{"issue":"Suppl 2","key":"10.1016\/j.mcna.2005.06.002_bib4","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1055\/s-2007-971984","article-title":"Heat acclimation\u2014mechanisms of adaptation to exercise in the heat","volume":"19","author":"Nielsen","year":"1998","journal-title":"Int J Sports Med"},{"issue":"2","key":"10.1016\/j.mcna.2005.06.002_bib5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/00000542-200202000-00036","article-title":"Perioperative shivering: physiology and pharmacology","volume":"96","author":"De Witte","year":"2002","journal-title":"Anesthesiology"},{"issue":"5","key":"10.1016\/j.mcna.2005.06.002_bib6","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0028-3908(02)00016-3","article-title":"Presence of alpha-1 adrenoreceptors on thermosensitive neurons in the medial preoptico-anterior hypothalamic area in rats","volume":"42","author":"Mallick","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mcna.2005.06.002_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1113\/jphysiol.1980.sp013147","article-title":"Further evidence for a physiological role for hypothalamic dopamine in thermoregulation in the rat","volume":"300","author":"Cox","year":"1980","journal-title":"J Physiol"},{"issue":"1\u20132","key":"10.1016\/j.mcna.2005.06.002_bib8","first-page":"1","article-title":"CNS regulation of thermogenesis","volume":"8","author":"Rothwell","year":"1994","journal-title":"Crit Rev Neurobiol"},{"issue":"2 Pt 1","key":"10.1016\/j.mcna.2005.06.002_bib9","first-page":"E181","article-title":"Sympathoadrenal system and regulation of thermogenesis","volume":"247","author":"Landsberg","year":"1984","journal-title":"Am J Physiol"},{"key":"10.1016\/j.mcna.2005.06.002_bib10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev.pharmtox.40.1.353","article-title":"Mitochondrial targets of drug toxicity","volume":"40","author":"Wallace","year":"2000","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.mcna.2005.06.002_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/eje.0.1390001","article-title":"The uncoupling proteins, a review","volume":"139","author":"Boss","year":"1998","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.mcna.2005.06.002_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.1984.64.1.1","article-title":"Thermogenic mechanisms in brown fat","volume":"64","author":"Nicholls","year":"1984","journal-title":"Physiol Rev"},{"issue":"1","key":"10.1016\/j.mcna.2005.06.002_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-5793(97)00384-0","article-title":"Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression","volume":"408","author":"Boss","year":"1997","journal-title":"FEBS Lett"},{"issue":"2\u20133","key":"10.1016\/j.mcna.2005.06.002_bib14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0005-2728(01)00168-2","article-title":"Cold-induced changes in the energy coupling and the UCP3 level in rodent skeletal muscles","volume":"1505","author":"Simonyan","year":"2001","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.mcna.2005.06.002_bib15","doi-asserted-by":"crossref","first-page":"E314","DOI":"10.1152\/ajpendo.2000.279.2.E314","article-title":"Evidence of UCP1-independent regulation of norepinephrine-induced thermogenesis in brown fat","volume":"279","author":"Ribeiro","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"39","key":"10.1016\/j.mcna.2005.06.002_bib16","doi-asserted-by":"crossref","first-page":"24129","DOI":"10.1074\/jbc.272.39.24129","article-title":"Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, beta 3-adrenergic agonists, and leptin","volume":"272","author":"Gong","year":"1997","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.mcna.2005.06.002_bib17","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1210\/en.136.8.3267","article-title":"Effects of thyroid hormone on norepinephrine signaling in brown adipose tissue. I. Beta 1- and beta 2-adrenergic receptors and cyclic adenosine 3\u2032,5\u2032\u2013monophosphate generation","volume":"136","author":"Rubio","year":"1995","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.mcna.2005.06.002_bib18","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1210\/en.139.2.571","article-title":"Thyroxine 5\u2032-deiodination mediates norepinephrine-induced lipogenesis in dispersed brown adipocytes","volume":"139","author":"Bianco","year":"1998","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.mcna.2005.06.002_bib19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1089\/thy.1995.5.481","article-title":"Thyroid hormone control of thermogenesis and energy balance","volume":"5","author":"Silva","year":"1995","journal-title":"Thyroid"},{"issue":"Suppl 6","key":"10.1016\/j.mcna.2005.06.002_bib20","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1038\/sj.ijo.0800948","article-title":"Thyroid hormone and other regulators of uncoupling proteins","volume":"23","author":"Reitman","year":"1999","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"4","key":"10.1016\/j.mcna.2005.06.002_bib21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0735-6757(84)90178-5","article-title":"Severe hyperthermia secondary to intravenous drug abuse","volume":"2","author":"Roberts","year":"1984","journal-title":"Am J Emerg Med"},{"issue":"4","key":"10.1016\/j.mcna.2005.06.002_bib22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.7326\/0003-4819-86-4-381","article-title":"Rhabdomyolysis and shock after intravenous amphetamine administration","volume":"86","author":"Kendrick","year":"1977","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.mcna.2005.06.002_bib23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/0003-4819-73-1-81","article-title":"Amphetamine intoxication with coagulopathy, hyperthermia, and reversible renal failure. A syndrome resembling heatstroke","volume":"73","author":"Ginsberg","year":"1970","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.mcna.2005.06.002_bib24","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/BF02044131","article-title":"MDMA induced hyperthermia: report of a fatality and review of current therapy","volume":"22","author":"Dar","year":"1996","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1016\/j.mcna.2005.06.002_bib25","doi-asserted-by":"crossref","first-page":"240","DOI":"10.5694\/j.1326-5377.2002.tb04385.x","article-title":"Serotonin toxicity with therapeutic doses of dexamphetamine and venlafaxine","volume":"176","author":"Prior","year":"2002","journal-title":"Med J Aust"},{"issue":"2","key":"10.1016\/j.mcna.2005.06.002_bib26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1212\/WNL.45.2.219","article-title":"Serotonin syndrome","volume":"45","author":"Bodner","year":"1995","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.mcna.2005.06.002_bib27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1474-4422(03)00439-3","article-title":"Convulsive ergotism: epidemics of the serotonin syndrome?","volume":"2","author":"Eadie","year":"2003","journal-title":"Lancet Neurol"},{"issue":"4234","key":"10.1016\/j.mcna.2005.06.002_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1126\/science.769159","article-title":"Ergotism: the satan loosed in Salem?","volume":"192","author":"Caporael","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.mcna.2005.06.002_bib29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.7326\/0003-4819-42-2-417","article-title":"Fatal toxic encephalitis occurring during iproniazid therapy in pulmonary tuberculosis","volume":"42","author":"Mitchell","year":"1955","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.mcna.2005.06.002_bib30","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJM198803243181209","article-title":"The Libby Zion case. One step forward or two steps backward?","volume":"318","author":"Asch","year":"1988","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.mcna.2005.06.002_bib31","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0749-0704(05)70368-7","article-title":"Serotonin syndrome. A clinical update","volume":"13","author":"Mills","year":"1997","journal-title":"Crit Care Clin"},{"issue":"6","key":"10.1016\/j.mcna.2005.06.002_bib32","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1176\/ajp.148.6.705","article-title":"The serotonin syndrome","volume":"148","author":"Sternbach","year":"1991","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.mcna.2005.06.002_bib33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF03033064","article-title":"Serotonin syndrome and drug combinations: focus on MAOI and RIMA","volume":"247","author":"Hilton","year":"1997","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"3","key":"10.1016\/j.mcna.2005.06.002_bib34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1054\/mehy.2000.1047","article-title":"An exploratory approach to the serotonin syndrome: an update of clinical phenomenology and revised diagnostic criteria","volume":"55","author":"Radomski","year":"2000","journal-title":"Med Hypotheses"},{"issue":"2","key":"10.1016\/j.mcna.2005.06.002_bib35","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/jcp.49.2.149","article-title":"Pathology of deaths associated with \u201cecstasy\u201d and \u201ceve\u201d misuse","volume":"49","author":"Milroy","year":"1996","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.mcna.2005.06.002_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/09595230220119363","article-title":"The health effects of ecstasy: a literature review","volume":"21","author":"Gowing","year":"2002","journal-title":"Drug Alcohol Rev"},{"issue":"4","key":"10.1016\/j.mcna.2005.06.002_bib37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00005792-200007000-00001","article-title":"Serotonin syndrome. Presentation of 2 cases and review of the literature","volume":"79","author":"Mason","year":"2000","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.mcna.2005.06.002_bib38","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0736-4679(97)00078-4","article-title":"Isolated venlafaxine-induced serotonin syndrome","volume":"15","author":"Kolecki","year":"1997","journal-title":"J Emerg Med"},{"issue":"10","key":"10.1016\/j.mcna.2005.06.002_bib39","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1176\/ajp.149.10.1410b","article-title":"The serotonin syndrome","volume":"149","author":"Lejoyeux","year":"1992","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.mcna.2005.06.002_bib40","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/0735-6757(94)90031-0","article-title":"The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease","volume":"12","author":"Skop","year":"1994","journal-title":"Am J Emerg Med"},{"issue":"5","key":"10.1016\/j.mcna.2005.06.002_bib41","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00004714-198109000-00009","article-title":"Toxicity secondary to meperidine in patients on monoamine oxidase inhibitors: a case report and critical review","volume":"1","author":"Meyer","year":"1981","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.mcna.2005.06.002_bib42","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00004714-198606000-00022","article-title":"L-dopa induced \u201cserotonin syndrome\u201d in a parkinsonian patient on bromocriptine","volume":"6","author":"Sandyk","year":"1986","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"10.1016\/j.mcna.2005.06.002_bib43","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1176\/appi.ajp.161.6.1129","article-title":"Serotonin syndrome with tramadol and citalopram","volume":"161","author":"Mahlberg","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"10","key":"10.1016\/j.mcna.2005.06.002_bib44","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1176\/ajp.150.10.1565","article-title":"Serotonin syndrome produced by a combination of fluoxetine and lithium","volume":"150","author":"Muly","year":"1993","journal-title":"Am J Psychiatry"},{"issue":"13","key":"10.1016\/j.mcna.2005.06.002_bib45","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1523\/JNEUROSCI.18-13-05086.1998","article-title":"Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)\u2013induced serotonin neurotoxicity and core body temperature in the rat","volume":"18","author":"Malberg","year":"1998","journal-title":"J Neurosci"},{"issue":"1\u20132","key":"10.1016\/j.mcna.2005.06.002_bib46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0006-8993(09)90007-5","article-title":"Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice","volume":"658","author":"Ali","year":"1994","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.mcna.2005.06.002_bib47","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0013-9351(02)00051-8","article-title":"Elevated environmental temperature and methamphetamine neurotoxicity","volume":"92","author":"Miller","year":"2003","journal-title":"Environ Res"},{"issue":"2","key":"10.1016\/j.mcna.2005.06.002_bib48","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0091-3057(91)90288-D","article-title":"Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat","volume":"38","author":"Gordon","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"issue":"22","key":"10.1016\/j.mcna.2005.06.002_bib49","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1001\/jama.279.22.1795","article-title":"Ambient temperature and mortality from unintentional cocaine overdose","volume":"279","author":"Marzuk","year":"1998","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.mcna.2005.06.002_bib50","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.tox.2004.07.012","article-title":"Strenuous exercise aggravates MDMA-induced skeletal muscle damage in mice","volume":"206","author":"Duarte","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.mcna.2005.06.002_bib51","first-page":"47","article-title":"The effect of exercise and limitation of movement on amphetamine toxicity","volume":"145","author":"Harding","year":"1963","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.mcna.2005.06.002_bib52","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1124\/jpet.104.079236","article-title":"The role of mitochondrial uncoupling in 3,4-methylenedioxymethamphetamine mediated skeletal muscle hyperthermia and rhabdomyolysis","volume":"313","author":"Rusyniak","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"8816","key":"10.1016\/j.mcna.2005.06.002_bib53","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0140-6736(92)91469-O","article-title":"Toxicity and deaths from 3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d)","volume":"340","author":"Henry","year":"1992","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.mcna.2005.06.002_bib54","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/sj.bjp.0705823","article-title":"Attenuation of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)\u2013induced rhabdomyolysis with alpha1- plus beta3-adrenoreceptor antagonists","volume":"142","author":"Sprague","year":"2004","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.mcna.2005.06.002_bib55","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0306-4522(99)00049-4","article-title":"The distribution of 3,4-methylenedioxymethamphetamine \u201cEcstasy\u201d\u2013induced c-fos expression in rat brain","volume":"92","author":"Stephenson","year":"1999","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.mcna.2005.06.002_bib56","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0197-0186(02)00213-9","article-title":"Diazepam and chlormethiazole attenuate the development of hyperthermia in an animal model of the serotonin syndrome","volume":"43","author":"Nisijima","year":"2003","journal-title":"Neurochem Int"},{"issue":"1","key":"10.1016\/j.mcna.2005.06.002_bib57","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s002130000397","article-title":"Risperidone counteracts lethality in an animal model of the serotonin syndrome","volume":"150","author":"Nisijima","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.mcna.2005.06.002_bib58","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.pnpbp.2004.01.013","article-title":"Extracellular serotonin, dopamine and glutamate levels are elevated in the hypothalamus in a serotonin syndrome animal model induced by tranylcypromine and fluoxetine","volume":"28","author":"Shioda","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.mcna.2005.06.002_bib59","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/01.jcp.0000088920.02635.5a","article-title":"Abnormal CSF monoamine metabolism in serotonin syndrome","volume":"23","author":"Nisijima","year":"2003","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.mcna.2005.06.002_bib60","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00004714-200002000-00022","article-title":"Abnormal monoamine metabolism in cerebrospinal fluid in a case of serotonin syndrome","volume":"20","author":"Nisijima","year":"2000","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.mcna.2005.06.002_bib61","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1460-9568.2002.02110.x","article-title":"Influences of the corticotropic axis and sympathetic activity on neurochemical consequences of 3,4-methylenedioxymethamphetamine (MDMA) administration in Fischer 344 rats","volume":"16","author":"Fernandez","year":"2002","journal-title":"Eur J Neurosci"},{"issue":"1","key":"10.1016\/j.mcna.2005.06.002_bib62","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1124\/jpet.102.044982","article-title":"Hypothalamic-pituitary-thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3,4-methylenedioxymethamphetamine (Ecstasy)","volume":"305","author":"Sprague","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"10.1016\/j.mcna.2005.06.002_bib63","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.bcp.2004.03.049","article-title":"UCP3 and thyroid hormone involvement in methamphetamine-induced hyperthermia","volume":"68","author":"Sprague","year":"2004","journal-title":"Biochem Pharmacol"},{"issue":"2\u20133","key":"10.1016\/j.mcna.2005.06.002_bib64","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-2999(98)00758-4","article-title":"Sympatho-adrenal involvement in methamphetamine-induced hyperthermia through skeletal muscle hypermetabolism","volume":"363","author":"Makisumi","year":"1998","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.mcna.2005.06.002_bib65","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/01.CCM.0000165969.29002.70","article-title":"Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal model","volume":"33","author":"Sprague","year":"2005","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.mcna.2005.06.002_bib66","first-page":"259","article-title":"Plasma concentrations of 5-HT, 5-HIAA, norepinephrine, epinephrine and dopamine in ecstasy users","volume":"23","author":"Stuerenburg","year":"2002","journal-title":"Neuro Endocrinol Lett"},{"issue":"21","key":"10.1016\/j.mcna.2005.06.002_bib67","doi-asserted-by":"crossref","first-page":"8648","DOI":"10.1523\/JNEUROSCI.21-21-08648.2001","article-title":"Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4-methylenedioxymethamphetamine (ecstasy) in conscious rabbits","volume":"21","author":"Pedersen","year":"2001","journal-title":"J Neurosci"},{"issue":"11","key":"10.1016\/j.mcna.2005.06.002_bib68","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/0003-4819-136-11-200206040-00006","article-title":"Mechanism of cocaine-induced hyperthermia in humans","volume":"136","author":"Crandall","year":"2002","journal-title":"Ann Intern Med"},{"issue":"52","key":"10.1016\/j.mcna.2005.06.002_bib69","doi-asserted-by":"crossref","first-page":"32847","DOI":"10.1074\/jbc.272.52.32847","article-title":"Alpha1-adrenergic stimulation potentiates the thermogenic action of beta3-adrenoreceptor\u2013generated cAMP in brown fat cells","volume":"272","author":"Zhao","year":"1997","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.mcna.2005.06.002_bib70","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00109-004-0591-7","article-title":"The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine","volume":"82","author":"Mills","year":"2004","journal-title":"J Mol Med"},{"key":"10.1016\/j.mcna.2005.06.002_bib71","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/426403a","article-title":"Uncoupling the agony from ecstasy","volume":"426","author":"Mills","year":"2003","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mcna.2005.06.002_bib72","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0006-8993(00)03020-1","article-title":"Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome","volume":"890","author":"Nisijima","year":"2001","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.mcna.2005.06.002_bib73","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.bjp.0704442","article-title":"The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d) to rats","volume":"135","author":"Mechan","year":"2002","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.mcna.2005.06.002_bib74","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00008877-200207000-00008","article-title":"Role of 5-HT(2) receptors in the tryptamine-induced 5-HT syndrome in rats","volume":"13","author":"Van Oekelen","year":"2002","journal-title":"Behav Pharmacol"},{"issue":"15","key":"10.1016\/j.mcna.2005.06.002_bib75","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.1523\/JNEUROSCI.23-15-06385.2003","article-title":"Clozapine reverses hyperthermia and sympathetically mediated cutaneous vasoconstriction induced by 3,4-methylenedioxymethamphetamine (ecstasy) in rabbits and rats","volume":"23","author":"Blessing","year":"2003","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.mcna.2005.06.002_bib76","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00000542-200407000-00053","article-title":"Dantrolene use in 3,4-methylenedioxymethamphetamine (ecstasy)\u2013mediated hyperthermia","volume":"101","author":"Rusyniak","year":"2004","journal-title":"Anesthesiology"},{"issue":"8","key":"10.1016\/j.mcna.2005.06.002_bib77","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1365-2044.1992.tb02391.x","article-title":"An overdose of ecstasy. A role for dantrolene","volume":"47","author":"Singarajah","year":"1992","journal-title":"Anaesthesia"},{"issue":"12","key":"10.1016\/j.mcna.2005.06.002_bib78","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1365-2044.1993.tb07526.x","article-title":"Exertional heat stroke induced by amphetamine analogues. Does dantrolene have a place?","volume":"48","author":"Watson","year":"1993","journal-title":"Anaesthesia"},{"issue":"6","key":"10.1016\/j.mcna.2005.06.002_bib79","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2044.1993.tb07102.x","article-title":"Ecstasy intoxication: appreciation of complications and the role of dantrolene","volume":"48","author":"Webb","year":"1993","journal-title":"Anaesthesia"},{"issue":"4","key":"10.1016\/j.mcna.2005.06.002_bib80","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0736-4679(98)00057-2","article-title":"Treatment of the serotonin syndrome with cyproheptadine","volume":"16","author":"Graudins","year":"1998","journal-title":"J Emerg Med"},{"issue":"15","key":"10.1016\/j.mcna.2005.06.002_bib81","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJM199410133311514","article-title":"Treatment of the serotonin syndrome with cyproheptadine","volume":"331","author":"Lappin","year":"1994","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.mcna.2005.06.002_bib82","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/026988119901300111","article-title":"The serotonin syndrome and its treatment","volume":"13","author":"Gillman","year":"1999","journal-title":"J Psychopharmacol"},{"issue":"9","key":"10.1016\/j.mcna.2005.06.002_bib83","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/0028-3908(84)90136-9","article-title":"Effects of psychoactive drugs on plasma catecholamines during stress in rats","volume":"23","author":"Vogel","year":"1984","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.mcna.2005.06.002_bib84","first-page":"189","article-title":"The effect of extracorporeal cooling on amphetamine toxicity","volume":"159","author":"Zalis","year":"1966","journal-title":"Arch Int Pharmacodyn Ther"},{"issue":"8","key":"10.1016\/j.mcna.2005.06.002_bib85","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2165\/00007256-200434080-00002","article-title":"Heat stroke: a review of cooling methods","volume":"34","author":"Hadad","year":"2004","journal-title":"Sports Med"},{"issue":"4","key":"10.1016\/j.mcna.2005.06.002_bib86","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/00024382-200304000-00016","article-title":"Hypothermia attenuates circulatory shock and cerebral ischemia in experimental heatstroke","volume":"19","author":"Chou","year":"2003","journal-title":"Shock"},{"issue":"9","key":"10.1016\/j.mcna.2005.06.002_bib87","first-page":"395","article-title":"Recognition, assessment and management of neuroleptic malignant syndrome","volume":"53","author":"Khan","year":"2000","journal-title":"S D J Med"},{"issue":"4","key":"10.1016\/j.mcna.2005.06.002_bib88","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4088\/JCP.v65n0403","article-title":"Neuroleptic malignant syndrome and atypical antipsychotic drugs","volume":"65","author":"Ananth","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"868","key":"10.1016\/j.mcna.2005.06.002_bib89","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/pgmj.74.868.72","article-title":"The neuroleptic malignant syndrome: a logical approach to the patient with temperature and rigidity","volume":"74","author":"Balzan","year":"1998","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.mcna.2005.06.002_bib90","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0733-8627(05)70127-9","article-title":"The neuroleptic malignant and serotonin syndromes","volume":"18","author":"Carbone","year":"2000","journal-title":"Emerg Med Clin North Am"},{"issue":"1","key":"10.1016\/j.mcna.2005.06.002_bib91","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0025-7125(16)30278-4","article-title":"Neuroleptic malignant syndrome","volume":"77","author":"Caroff","year":"1993","journal-title":"Med Clin North Am"},{"issue":"5 Pt 1","key":"10.1016\/j.mcna.2005.06.002_bib92","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/clpt.1991.184","article-title":"Facilitating prompt diagnosis and treatment of the neuroleptic malignant syndrome","volume":"50","author":"Nierenberg","year":"1991","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.mcna.2005.06.002_bib93","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1176\/ajp.146.6.717","article-title":"A prospective analysis of 24 episodes of neuroleptic malignant syndrome","volume":"146","author":"Rosebush","year":"1989","journal-title":"Am J Psychiatry"},{"issue":"5","key":"10.1016\/j.mcna.2005.06.002_bib94","doi-asserted-by":"crossref","first-page":"228","DOI":"10.5694\/j.1326-5377.1973.tb128791.x","article-title":"Mutism and hyperthermia in a patient treated with neuroleptics","volume":"2","author":"Oppenheim","year":"1973","journal-title":"Med J Aust"},{"key":"10.1016\/j.mcna.2005.06.002_bib95","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00005053-199403000-00007","article-title":"Progression of symptoms in neuroleptic malignant syndrome","volume":"182","author":"Velamoor","year":"1994","journal-title":"J Nerv Ment Dis"},{"issue":"8760","key":"10.1016\/j.mcna.2005.06.002_bib96","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0140-6736(91)90138-F","article-title":"Serum iron and neuroleptic malignant syndrome","volume":"338","author":"Rosebush","year":"1991","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.mcna.2005.06.002_bib97","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1001\/archinte.147.8.1495","article-title":"Metoclopramide-induced neuroleptic malignant syndrome","volume":"147","author":"Friedman","year":"1987","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.mcna.2005.06.002_bib98","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0736-4679(96)00186-2","article-title":"Prochlorperazine-induced neuroleptic malignant syndrome","volume":"14","author":"Pesola","year":"1996","journal-title":"J Emerg Med"},{"issue":"10","key":"10.1016\/j.mcna.2005.06.002_bib99","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/00007611-199910000-00015","article-title":"Neuroleptic malignant syndrome due to promethazine","volume":"92","author":"Chan-Tack","year":"1999","journal-title":"South Med J"},{"issue":"5","key":"10.1016\/j.mcna.2005.06.002_bib100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/00325481.1991.11700900","article-title":"Neuroleptic malignant syndrome. When levodopa withdrawal is the cause","volume":"89","author":"Rainer","year":"1991","journal-title":"Postgrad Med"},{"issue":"7","key":"10.1016\/j.mcna.2005.06.002_bib101","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/00007611-198807000-00020","article-title":"Neuroleptic malignant syndrome: guidelines for treatment and reinstitution of neuroleptics","volume":"81","author":"Olmsted","year":"1988","journal-title":"South Med J"},{"issue":"2","key":"10.1016\/j.mcna.2005.06.002_bib102","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1212\/WNL.31.2.132","article-title":"Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?","volume":"31","author":"Henderson","year":"1981","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.mcna.2005.06.002_bib103","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1176\/ajp.156.2.169","article-title":"Sympathoadrenal hyperactivity and the etiology of neuroleptic malignant syndrome","volume":"156","author":"Gurrera","year":"1999","journal-title":"Am J Psychiatry"},{"issue":"5","key":"10.1016\/j.mcna.2005.06.002_bib104","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0006-3223(95)00389-4","article-title":"Cerebrospinal fluid monoamine metabolism in a case of neuroleptic malignant syndrome improved by electroconvulsive therapy","volume":"39","author":"Nisijima","year":"1996","journal-title":"Biol Psychiatry"},{"issue":"8","key":"10.1016\/j.mcna.2005.06.002_bib105","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1176\/ajp.138.8.1115","article-title":"Sympathoadrenomedullary hyperactivity in the neuroleptic malignant syndrome: a case report","volume":"138","author":"Feibel","year":"1981","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.mcna.2005.06.002_bib106","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0006-3223(92)90037-Z","article-title":"Sympathoadrenomedullary activity in the neuroleptic malignant syndrome","volume":"32","author":"Gurrera","year":"1992","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.mcna.2005.06.002_bib107","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1034\/j.1600-0447.2000.102003226.x","article-title":"Prospective evaluation of circulatory levels of catecholamines and serotonin in neuroleptic malignant syndrome","volume":"102","author":"Spivak","year":"2000","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"10.1016\/j.mcna.2005.06.002_bib108","first-page":"69","article-title":"Bromocriptine treatment of neuroleptic malignant syndrome","volume":"48","author":"Dhib-Jalbut","year":"1987","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"10.1016\/j.mcna.2005.06.002_bib109","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1097\/00007611-198612000-00022","article-title":"Successful treatment of neuroleptic malignant syndrome with bromocriptine","volume":"79","author":"Janati","year":"1986","journal-title":"South Med J"},{"issue":"6","key":"10.1016\/j.mcna.2005.06.002_bib110","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/0006-3223(85)90104-0","article-title":"Neuroleptic malignant syndrome: successful treatment with bromocriptine","volume":"20","author":"Verhoeven","year":"1985","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.mcna.2005.06.002_bib111","first-page":"193","article-title":"Dantrolene\u2014a new therapeutic approach to the neuroleptic malignant syndrome","volume":"100","author":"Bismuth","year":"1984","journal-title":"Acta Neurol Scand Suppl"},{"issue":"3","key":"10.1016\/j.mcna.2005.06.002_bib112","first-page":"381","article-title":"Drug treatment of the neuroleptic malignant syndrome","volume":"27","author":"Sakkas","year":"1991","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.mcna.2005.06.002_bib113","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1192\/bjp.159.5.709","article-title":"The treatment of neuroleptic malignant syndrome. Are dantrolene and bromocriptine useful adjuncts to supportive care?","volume":"159","author":"Rosebush","year":"1991","journal-title":"Br J Psychiatry"},{"issue":"7","key":"10.1016\/j.mcna.2005.06.002_bib114","first-page":"283","article-title":"Neuroleptic malignant syndrome, bromocriptine, and anticholinergic drugs","volume":"49","author":"Schvehla","year":"1988","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"10.1016\/j.mcna.2005.06.002_bib115","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/070674379504000907","article-title":"Management of suspected neuroleptic malignant syndrome","volume":"40","author":"Velamoor","year":"1995","journal-title":"Can J Psychiatry"},{"issue":"12","key":"10.1016\/j.mcna.2005.06.002_bib116","first-page":"1441","article-title":"Chlorpromazine-induced neuroleptic malignant syndrome and its response to diazepam","volume":"18","author":"Lew","year":"1983","journal-title":"Biol Psychiatry"},{"issue":"6","key":"10.1016\/j.mcna.2005.06.002_bib117","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1176\/ajp.154.6.882","article-title":"Diazepam-responsive neuroleptic malignant syndrome: a diagnostic subtype?","volume":"154","author":"Miyaoka","year":"1997","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.mcna.2005.06.002_bib118","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1600-0447.1988.tb06355.x","article-title":"Treatment of a mild form of neuroleptic malignant syndrome with oral diazepam","volume":"78","author":"Kontaxakis","year":"1988","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"10.1016\/j.mcna.2005.06.002_bib119","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/jnnp.74.5.574","article-title":"Efficacy of methylprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson\u2019s disease","volume":"74","author":"Sato","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/j.mcna.2005.06.002_bib120","first-page":"295","article-title":"Twenty neuroleptic rechallenges after neuroleptic malignant syndrome in 15 patients","volume":"50","author":"Rosebush","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.mcna.2005.06.002_bib121","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0140-6736(60)92690-8","article-title":"Anaesthetic deaths in a family","volume":"2","author":"Denborough","year":"1960","journal-title":"Lancet"},{"issue":"352","key":"10.1016\/j.mcna.2005.06.002_bib122","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0140-6736(98)03078-5","article-title":"Malignant hyperthermia","volume":"9134","author":"Denborough","year":"1998","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.mcna.2005.06.002_bib123","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0002-9343(98)00108-9","article-title":"Malignant hyperthermia and central core disease: disorders of Ca2+ release channels","volume":"104","author":"Loke","year":"1998","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.mcna.2005.06.002_bib124","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/bja\/85.1.118","article-title":"Malignant hyperthermia: advances in clinical management and diagnosis","volume":"85","author":"Hopkins","year":"2000","journal-title":"Br J Anaesth"},{"issue":"2","key":"10.1016\/j.mcna.2005.06.002_bib125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/00002018-199818020-00002","article-title":"Adverse effects of neuromuscular blockers and their antagonists","volume":"18","author":"Naguib","year":"1998","journal-title":"Drug Saf"},{"issue":"2","key":"10.1016\/j.mcna.2005.06.002_bib126","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/jama.286.2.168","article-title":"Malignant hyperthermia and apparent heat stroke","volume":"286","author":"Tobin","year":"2001","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.mcna.2005.06.002_bib127","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00000542-200101000-00019","article-title":"Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysis","volume":"94","author":"Wappler","year":"2001","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.mcna.2005.06.002_bib128","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0031-3955(16)38700-4","article-title":"Malignant hyperthermia","volume":"41","author":"Kaus","year":"1994","journal-title":"Pediatr Clin North Am"},{"issue":"8","key":"10.1016\/j.mcna.2005.06.002_bib129","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1399-6576.1990.tb03172.x","article-title":"The role of sympathetic activity in initiating malignant hyperthermia","volume":"34","author":"Haggendal","year":"1990","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.mcna.2005.06.002_bib130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0378-4347(00)82008-3","article-title":"Plasma levels of norepinephrine and epinephrine during malignant hyperthermia in susceptible pigs","volume":"344","author":"Williams","year":"1985","journal-title":"J Chromatogr"},{"issue":"9","key":"10.1016\/j.mcna.2005.06.002_bib131","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/bja\/48.9.831","article-title":"Porcine malignant hyperthermia. III. Adrenergic blockade","volume":"48","author":"Lister","year":"1976","journal-title":"Br J Anaesth"},{"issue":"3","key":"10.1016\/j.mcna.2005.06.002_bib132","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/bja\/50.3.241","article-title":"Porcine malignant hyperthermia. VI. The effects of bilateral adrenalectomy and pretreatment with bretylium on the halothane-induced response","volume":"50","author":"Lucke","year":"1978","journal-title":"Br J Anaesth"},{"issue":"4","key":"10.1016\/j.mcna.2005.06.002_bib133","first-page":"790","article-title":"Norepinephrine does not potentiate porcine malignant hyperthermia","volume":"82","author":"Maccani","year":"1996","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.mcna.2005.06.002_bib134","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0014-2999(92)90016-W","article-title":"Increase of serotonin in plasma during onset of halothane-induced malignant hyperthermia in pigs","volume":"220","author":"Gerdes","year":"1992","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.mcna.2005.06.002_bib135","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF00171727","article-title":"Pharmacodynamic effects of serotonin (5-HT) receptor ligands in pigs: stimulation of 5-HT2 receptors induces malignant hyperthermia","volume":"341","author":"Loscher","year":"1990","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"5","key":"10.1016\/j.mcna.2005.06.002_bib136","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/00000542-200311000-00020","article-title":"Induction of malignant hyperthermia in susceptible swine by 3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d)","volume":"99","author":"Fiege","year":"2003","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.mcna.2005.06.002_bib137","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/bja\/aeg172","article-title":"Effects of a 5HT(2) receptor agonist on anaesthetized pigs susceptible to malignant hyperthermia","volume":"91","author":"Gerbershagen","year":"2003","journal-title":"Br J Anaesth"},{"issue":"4","key":"10.1016\/j.mcna.2005.06.002_bib138","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF00178953","article-title":"Lack of prophylactic or therapeutic efficacy of 5-HT2A receptor antagonists in halothane-induced porcine malignant hyperthermia","volume":"350","author":"Loscher","year":"1994","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"2","key":"10.1016\/j.mcna.2005.06.002_bib139","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2165\/00003495-198632020-00003","article-title":"Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity","volume":"32","author":"Ward","year":"1986","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.mcna.2005.06.002_bib140","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1097\/00000542-199606000-00013","article-title":"Dantrolene sodium can increase or attenuate activity of skeletal muscle ryanodine receptor calcium release channel: clinical implications","volume":"84","author":"Nelson","year":"1996","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.mcna.2005.06.002_bib141","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/(SICI)1097-4598(200001)23:1<4::AID-MUS3>3.0.CO;2-D","article-title":"Genetics and pathogenesis of malignant hyperthermia","volume":"23","author":"Jurkat-Rott","year":"2000","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.mcna.2005.06.002_bib142","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4065\/70.3.241","article-title":"Clinical effects of intravenously administered dantrolene","volume":"70","author":"Wedel","year":"1995","journal-title":"Mayo Clin Proc"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712505000556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712505000556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T04:28:03Z","timestamp":1683260883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712505000556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":142,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0025712505000556"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2005.06.002","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}